Home

Astrazeneca Pharma India PE Ratio

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

PE

119.2

Last updated on: May 10, 2025

Key Highlights

  • The P/E Ratio of Astrazeneca Pharma India Ltd is 119.2 as of 10 May 11:42 AM .
  • The P/E Ratio of Astrazeneca Pharma India Ltd changed from 82.8 on March 2020 to 82.4 on March 2024 . This represents a CAGR of -0.10% over 5 years.
  • The Latest Trading Price of Astrazeneca Pharma India Ltd is ₹ 7992 as of 09 May 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 40.1 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.1. The PE Ratio of Pharmaceuticals industry is 40.1. The PE Ratio of Retail industry is 139.8. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Astrazeneca Pharma India Ltd

No data available

Company Fundamentals for Astrazeneca Pharma India Ltd

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

Share Price

₹ 7992.35

-183.85 (-2.25%)

stock direction

Last updated on: May 09, 2025

Market Price of Astrazeneca Pharma India Ltd

1M

1Y

3Y

5Y

Monitoring Astrazeneca Pharma India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 May 20257992.35
08 May 20258176.2
07 May 20258186.4
06 May 20258201.3
05 May 20258350.25
02 May 20258369.85
30 Apr 20258665.5
29 Apr 20258795.9
28 Apr 20258839.6
25 Apr 20258728.45

BlinkX Score for Astrazeneca Pharma India Ltd

Asset Value vs Market Value of Astrazeneca Pharma India Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Astrazeneca Pharma India Ltd19980
Sun Pharmaceutical Industries Ltd418648
Divis Laboratories Ltd159310
Cipla Ltd119410
Torrent Pharmaceuticals Ltd106184
Mankind Pharma Ltd99570

PE Ratio of Astrazeneca Pharma India Ltd Explained

19980

Market cap

96

Earnings

119.2X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Astrazeneca Pharma India Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Astrazeneca Pharma India Ltd

No data available

* All values are in %

About Astrazeneca Pharma India Ltd

  • AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979.
  • The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
  • The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
  • Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.

Astrazeneca Pharma India Ltd News Hub

AstraZeneca slumps on recording dismal Q1 performance

Revenue from operations jumped 31.15% year on year (YoY) to Rs 387.52 crore in the quarter ended 30

Read more

08 Aug 24

Astrazeneca Pharma India reports standalone net loss of Rs 11.79 crore in the June 2024 quarter

Net loss of Astrazeneca Pharma India reported to Rs 11.79 crore in the quarter ended June 2024 as ag

Read more

08 Aug 24

Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions

Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed by IMFINZI

Read more

24 Sept 24

Astrazeneca Pharma India Ltd leads gainers in 'A' group

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and National Alumini

Read more

24 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Astrazeneca Pharma India Ltd

What is the current PE Ratio of Astrazeneca Pharma India Ltd?

The Current PE Ratio of Astrazeneca Pharma India Ltd is 119.2 as on 10 May 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.1 as on 10 May 2025.

What was the PE Ratio of Astrazeneca Pharma India Ltd last year?

The PE Ratio of Astrazeneca Pharma India Ltd was 81.75 last year, now the PE ratio is 119.2, showing a year-on-year growth of 45.8%.

What does the PE Ratio of Astrazeneca Pharma India Ltd indicate about its stock?

The PE Ratio of Astrazeneca Pharma India Ltd is 119.2. This ratio indicates that investors are willing to pay 119.2 times the earnings per share for each share of Astrazeneca Pharma India Ltd.

What is the PE Ratio Growth of Astrazeneca Pharma India Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Astrazeneca Pharma India Ltd grew by 45.8% whereas, the EPS ratio grew by -24.6.

How does the PE ratio of Astrazeneca Pharma India Ltd compare to industry peers?

The PE ratio of Astrazeneca Pharma India Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Astrazeneca Pharma India Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Astrazeneca Pharma India Ltd PE Ratio.

What factors influence the PE ratio of Astrazeneca Pharma India Ltd PE Ratio?

The PE ratio of Astrazeneca Pharma India Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Astrazeneca Pharma India Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Astrazeneca Pharma India Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Astrazeneca Pharma India Ltd PE Ratio?

You can check the latest PE ratio of Astrazeneca Pharma India Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Astrazeneca Pharma India Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Astrazeneca Pharma India Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Astrazeneca Pharma India Ltd PE Ratio predict future stock performance?

While the Astrazeneca Pharma India Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions